Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GenVec - GNVC -- Ignore unavailable to you. Want to Upgrade?

To: Savant who wrote (36)	12/18/2011 12:07:14 AM
From: Gary Mohilner	Read Replies (1) \| Respond to of 106

I believe as retail investors we must hope that we're investing in companies that when the time is viewed as right, those institutions that do move stocks will do so in the up direction we're looking for. While I believe GNVC was punished far more than was justified on the PACT failure, I also have to believe that when positive data's seen, either in hearing drug trials, partnership of RSV, or other meaningful events, GNVC will be pushed up to levels not seen in some time, perhaps not ever. As long as the O/S is 30 million or less, payments that would be minor to big companies could be very big to GNVC on a relative basis. Gary